Moreover, some studies indicated that overexpression of RIPK4 could lead to resistance of chemotherapy and promote the progression and recurrence of cancers through activating NF-κB and Wnt/β-catenin signal pathways [18]. This evidence concerns the gene NFKB1 and cancer.